Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets Feb 11, 2009 Nektar Announces Retirement of Irwin Lerner from Board of Directors Jan 29, 2009 First Patient Dosed in Phase 2 Clinical Trial of NKTR-102 in Ovarian Cancer Jan 13, 2009 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco Jan 05, 2009 Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million Dec 31, 2008 Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results Nov 06, 2008 Nektar Therapeutics to Webcast R&D Day on November 12th Oct 27, 2008 Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium Oct 24, 2008 Positive Preclinical Data Demonstrating Anti-Tumor Activity of NKTR-105 (PEG-docetaxel) Presented at 20th EORTC-NCI-AACR Conference Oct 23, 2008 Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday, November 6, 2008 After Close of U.S.-Based Financial Markets Oct 23, 2008 Pagination First page « first Previous page ‹ previous … Page 41 Page 42 Page 43 Page 44 Current page 45 Page 46 Page 47 Page 48 Page 49 … Next page next › Last page last »